Page last updated: 2024-08-16

spiperone and vasoactive intestinal peptide

spiperone has been researched along with vasoactive intestinal peptide in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19903 (60.00)18.7374
1990's2 (40.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Agui, T; Munemura, M; Sibley, DR1
Day, RN; Hinkle, PM1
Fischette, CT; McEwen, BS; Rostene, WH1
Alberici, A; Memo, M; Spano, P; Tinti, C; Valerio, A1
Allard, S; Falardeau, P; Lapointe, S1

Other Studies

5 other study(ies) available for spiperone and vasoactive intestinal peptide

ArticleYear
Chronic estrogen treatment promotes a functional uncoupling of the D2 dopamine receptor in rat anterior pituitary gland.
    Endocrinology, 1989, Volume: 124, Issue:1

    Topics: Adenylyl Cyclases; Animals; Apomorphine; Binding, Competitive; Cell Membrane; Diethylstilbestrol; GTP-Binding Proteins; Guanine Nucleotides; Guanylyl Imidodiphosphate; Male; Organ Size; Pituitary Gland, Anterior; Prolactin; Rats; Rats, Inbred F344; Receptors, Dopamine; Receptors, Dopamine D2; Spiperone; Vasoactive Intestinal Peptide

1989
Transient dopaminergic inhibition of prolactin release from hybrid cells derived by fusion of normal rat pituitary and GH4C1 tumor cells.
    Endocrinology, 1988, Volume: 122, Issue:5

    Topics: Animals; Bromocriptine; Cell Fusion; Cell Line; Cells, Cultured; Dopamine; Female; Growth Hormone; Hybrid Cells; Pituitary Gland; Pituitary Neoplasms; Prolactin; Rats; Rats, Inbred WF; Spiperone; Thyrotropin-Releasing Hormone; Vasoactive Intestinal Peptide

1988
Modulation by vasoactive intestinal peptide (VIP) of serotonin receptors in membranes from rat hippocampus.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 1983, Volume: 3, Issue:12

    Topics: Animals; Binding Sites; Cell Membrane; Cells, Cultured; Cerebral Cortex; Hippocampus; Hypothalamus; Male; Pons; Rats; Rats, Inbred Strains; Receptors, Serotonin; Serotonin; Spiperone; Vasoactive Intestinal Peptide

1983
Antisense strategy unravels a dopamine receptor distinct from the D2 subtype, uncoupled with adenylyl cyclase, inhibiting prolactin release from rat pituitary cells.
    Journal of neurochemistry, 1994, Volume: 62, Issue:4

    Topics: Adenylyl Cyclase Inhibitors; Adenylyl Cyclases; Animals; Base Sequence; Bromocriptine; Cells, Cultured; Cyclic AMP; Female; Molecular Sequence Data; Oligonucleotides, Antisense; Pituitary Gland, Anterior; Polymerase Chain Reaction; Prolactin; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; RNA, Messenger; Spiperone; Vasoactive Intestinal Peptide

1994
Specific induction of a functional endogenous D2 short dopamine receptor in GH4C1 cells.
    Biochemical and biophysical research communications, 1993, Jun-15, Volume: 193, Issue:2

    Topics: Animals; Apomorphine; Base Sequence; Colforsin; Cyclic AMP; Dopamine; Dose-Response Relationship, Drug; Ergolines; Gene Expression; Kanamycin Kinase; Kinetics; Molecular Sequence Data; Oligodeoxyribonucleotides; Phosphotransferases; Pituitary Neoplasms; Polymerase Chain Reaction; Potassium Chloride; Prolactin; Quinpirole; Rats; Receptors, Dopamine D2; Recombinant Fusion Proteins; Spiperone; Sulpiride; Transfection; Tumor Cells, Cultured; Vasoactive Intestinal Peptide

1993